Waters is currently displaying its portfolio of products for clinical and research laboratories at this year's American Association for Clinical Chemistry (AACC) meeting, held 19 - 23 July in Chicago.
These products include a research use only (RUO) kit for quantitative measurement of tacrolimus, sirolimus, everolimus and cyclosporin.
Waters is presenting its Masstrak Immunosuppressants XE RUO Kit, which provides laboratories with an alternative to immunoassay test kits for research laboratory analyses.
Waters is also displaying other system platform solutions for amino acid analysis and for vitamin D clinical-research laboratories.
The Masstrak Immunosuppressants XE RUO Kit is suitable for clinical research laboratories seeking an alternative to immunoassay kits for quantitative measurement of immunosuppressant drug levels.
Each kit includes reagents, controls and calibrators, a tuning mixture for the mass spectrometer and an analytical column for performing up to 500 determinations/kit.
Used with Waters Acquity TQD System, the Masstrak Immunosuppressants XE RUO Kit achieves high specificity in measuring the target analyte in the presence of drug metabolites and addresses some of the analytical weaknesses of immunoassay immunosuppressant drug measurement.
For the first time at AACC, Waters is exhibiting a system platform optimised for 25-Hydroxyvitamin D analysis for clinical research laboratories.
This analytical system features a robotic liquid-handling system and Waters Acquity TQD System for high-throughput measurement of total 25-Hydroxyvitamin as well as 25-Hydroxyvitamin D2 and D3.
The test method features a solid-phase extraction sample preparation step that minimises solvent usage, enhances automation and eliminates the need for solvent evaporation and sample reconstitution.